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Abstract
Objective: Obesity and renin angiotensin system (RAS) hyperactivity are profoundly involved in cardiovascular diseases,
however aerobic exercise training (EXT) can prevent obesity and cardiac RAS activation. The study hypothesis was to
investigate whether obesity and its association with EXT alter the systemic and cardiac RAS components in an obese Zucker
rat strain.
Methods: The rats were divided into the following groups: Lean Zucker rats (LZR); lean Zucker rats plus EXT (LZR+EXT);
obese Zucker rats (OZR) and obese Zucker rats plus EXT (OZR+EXT). EXT consisted of 10 weeks of 60-min swimming
sessions, 5 days/week. At the end of the training protocol heart rate (HR), systolic blood pressure (SBP), cardiac hypertrophy
(CH) and function, local and systemic components of RAS were evaluated. Also, systemic glucose, triglycerides, total
cholesterol and its LDL and HDL fractions were measured.
Results: The resting HR decreased (,12%) for both LZR+EXT and OZR+EXT. However, only the LZR+EXT reached
significance (p,0.05), while a tendency was found for OZR versus OZR+EXT (p = 0.07). In addition, exercise reduced (57%)
triglycerides and (61%) LDL in the OZR+EXT. The systemic angiotensin I-converting enzyme (ACE) activity did not differ
regardless of obesity and EXT, however, the OZR and OZR+EXT showed (66%) and (42%), respectively, less angiotensin II
(Ang II) plasma concentration when compared with LZR. Furthermore, the results showed that EXT in the OZR prevented
increase in CH, cardiac ACE activity, Ang II and AT2 receptor caused by obesity. In addition, exercise augmented cardiac
ACE2 in both training groups.
Conclusion: Despite the unchanged ACE and lower systemic Ang II levels in obesity, the cardiac RAS was increased in OZR
and EXT in obese Zucker rats reduced some of the cardiac RAS components and prevented obesity-related CH. These results
show that EXT prevented the heart RAS hyperactivity and cardiac maladaptive morphological alterations in obese Zucker
rats.
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Introduction
According to the World Health Organization, over 1.7 billion
people worldwide are overweight or obese [1]. Moreover, obesity
is one of the major epidemics expanding in Western countries
today, and increases the prevalence of most cardiovascular risk
factors independently of other associated diseases. One of the most
common independent cardiac features in obesity is cardiac
hypertrophy (CH) [2–3]. The physiopathology of CH in obesity
is complex and involves several factors such as hemodynamic,
metabolic and neurohumoral factors [4].
The RAS is one of the most important neurohumoral
contributors to the progression of pathological CH [5]. In the
classical RAS pathway, angiotensinogen is cleaved by renin to
produce angiotensin I (Ang I), which is converted to angiotensin II
(Ang II) by angiotensin converting enzyme (ACE). Ang II is an
important factor in cardiac remodeling, growth and apoptosis
through the activation of specific receptors [5]. Nowadays, the
importance of RAS located in specific tissues, such as heart and
adipose tissue is well recognized, and its pharmacological
inhibition has gained support [6]. Some authors have demon-
strated that the use of ACE inhibitors can prevent obese cardiac
cardiomyopathy, with improvements in cardiac metabolism and
function, and reduction of CH in obese Zucker rats [7–8].
However, there is still controversy about the modulation of cardiac
RAS in obesity, since some studies have observed an increase in
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some of the components of cardiac RAS, whereas others found no
difference [9–11]. Furthermore, these results were demonstrated
in independent studies, so the literature lacks studies demonstrat-
ing the association between each of the RAS components with
obesity.
In addition, there is a growing body of evidence showing that
aerobic exercise training (EXT) can reduce a number of
cardiovascular risk factors [12–14]. Indeed, EXT has been
recognized as an important non-pharmacological strategy to
prevent obesity and related disorders. Furthermore, a recent study
in our lab demonstrated that EXT induces effects on the RAS,
such as decreased cardiac ACE and Ang II and increased cardiac
ACE2 and Ang 1–7 [15] in healthy rats. In addition, Pereira et al
[12] using a genetic mouse model also showed a beneficial effect of
aerobic exercise on cardiac RAS components. However, to the
best of our knowledge, the effect of EXT on cardiac RAS
components in obese rats has not been studied yet.
Therefore, the present study was undertaken to test 2
hypotheses: 1) Whether the cardiac and systemic RAS components
are changed in obese Zucker rats; and 2) Whether EXT alters the
RAS components and prevents pathological CH in obese Zucker
rats.
Materials and Methods
Experimental animals
Twenty male Zucker rats at 20 weeks of age were assigned to
four groups (n = 5 each): Lean Zucker rat (LZR), lean Zucker rat
plus exercise training (LZR+EXT), obese Zucker rat (OZR), obese
Zucker rat plus exercise training (OZR+EXT). The animals were
housed in standard cages and food and water were provided ad
libitum. The environmental temperature was kept at 2361uC and
an inverted 12:12 h dark-light cycle was maintained throughout
the experiment.
All protocols and surgical procedures used were in accordance
with the guidelines of the Brazilian College for Animal Experi-
mentation and were approved by the Ethics Committee (1023/07)
of the Institute of Biomedical Science of the University of Sao
Paulo.
Exercise protocol
Swimming training was performed as previously described [16].
Animals were trained in a swimming apparatus specially designed
to allow individual exercise training of rats in warm water at 30–
32uC. Physical training consisted of swimming sessions of 60-min
duration, 5 days/wk, for 10 wk, wearing caudal dumbbells
weighing 5% of their body weight. All animals were weighed
once a week and the workload was adjusted to body weight
variations. Sedentary groups were placed in the swimming
apparatus for 10 minutes twice a week without workload. This
protocol is defined as a low intensity, long training period, effective
for promoting cardiovascular adaptations and increase in muscle
oxidative capacity [16].
Arterial heart rate and systolic blood pressure
Heart rate (HR) and systolic blood pressure (SBP) were
determined non-invasively in the four experimental groups in
the last week of the training protocol, using a computerized tail-
cuff plethysmograph system (IITC Life Science Inc. CA USA).
Rats were acclimatized to the apparatus during daily sessions over
a period of 3 days.
Echocardiography
Echocardiography features were obtained in accordance with
the recommendations of the American Society of Echocardiogra-
phy [17]. The animals were anesthetized intraperitoneally with a
mixture of Xylazine (10 mg/kg) and ketamine (90 mg/kg).
Transthoracic echocardiography was performed in the last week
of the training protocol by only one observer using Sequoia 512
equipment (ACUSON Corporation, Mountain View, CA) and a
10 to 14 MHz multifrequency linear transducer. Images were
obtained with the transducer placed on the animal’s shaved chest
(lateral recumbence). All measurements were performed by the
same observer based on the average of 3 consecutive cardiac
cycles. Left ventricle (LV) mass was calculated using the following
formula, assuming a spherical LV geometry and validated for use
in rats: LV mass = 1.0476[(LVd+PWd+IWd)3-LVd3], where
1.047 is the specific gravity of muscle, LVd is LV end-diastolic
diameter and PWd and IWd are end-diastolic posterior and
interseptum wall thicknesses, respectively. LV shortening was
calculated as (LVd-LVs)/LVdx100, where LVs is LV end-systolic
diameter. LV ejection fraction was calculated according to the
Teichholz formula. Two-dimensionally guided pulsed Doppler
recordings of LV transmitral flow were obtained from the apical 4-
chamber view. E and A waves were measured by the peak velocity
of the mitral valve. The E wave represents passive ventricular
filling and the A wave represents active filling with atrial systole.
Isovolumic relaxation time was taken as the time from aortic valve
closure to the onset of mitral flow. The myocardial performance
index was calculated by the sum of isovolumic contraction time
and isovolumic relaxation time divided by the ejection time.
Blood and Tissue Harvesting
Twenty four hours after the last training session, the rats were
killed after twelve hours of fasting, by quick decapitation without
prior anesthesia and blood and tissue samples were harvested. In
addition, the LV, visceral fat pad (VFP) and tibia were harvested.
The VFP and LV were weighted. The tibia lengths were
determined and the hypertrophy index of each animal (weight of
LV in g/tibia length in cm) was calculated. The tissues, serum and
plasma were frozen at 280uC and used within 1 month for
enzyme assays and mRNA and protein preparations.
Serum glucose, cholesterol, HDL, LDL and triglycerides
Serum glucose, cholesterol, HDL, LDL and triglyceride levels
were measured by spectrophotometer according to the procedures
described in commercially available kits (Labtest).
Angiotensin-converting enzyme activity assay
ACE activity in rat serum and cardiac tissue (LV) extracts were
determined using Abz-FRK(DNP)P-OH derivatives as substrates
by continuously measuring the fluorescence according to Alves et
al [18]. Tissue samples were quickly harvested, homogenized in
Tris-HCl buffer, pH 7.0, containing 50 mM NaCl and centri-
fuged at 1000 g for 10 min. The assays were performed at 37uC in
0.1 M Tris-HCl buffer, pH 7.0, containing 50 mM NaCl and
10 mM ZnCl2. The hydrolysis rate of intramolecularly quenched
fluorogenic substrate Abz-YRK-(Dnp)p (10 mM) incubated with
aliquots of tissue homogenate and serum for 30 min at 37uC was
assessed to obtain ACE enzymatic activity. Fluorescence incre-
ments throughout the period of time were read at 420 nm
emission: 320 nm excitation. Tissue and serum ACE activity were
expressed as UF.min21.mg21of protein 61000. The protein
content was determined by the Bradford methods [19] using
bovine serum albumin as the standard (Bio-Rad Protein Assay).
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Cardiac angiotensin-converting enzyme 2 (ACE2) activity
ACE2 activity was determined in LV tissue by the same method
described above. However, this method uses a fluorescent peptide
Abz-APK(Dnp)-OH in 0.2 M Tris-HCl buffer, 200 mM NaCl,
2 mg BSA, pH 7.5, which is hydrolyzed by ACE2 (Kcat/
Km=3,56104 M21.s21). ACE2 activity was expressed in UF.-
min21.mg21of protein.
Measurement of Angiotensin II
Plasma and LV Ang II levels were determined by ELISA,
according to the manufacturer’s instructions (SPI-BIO). To
determine plasma Ang II concentration the first 3 ml of trunk
blood was rapidly collected in chilled glass tubes containing a
mixture of protease inhibitors [potassium EDTA (25 mmol), o-
phenanthroline (0.44 mmol), pepstatin A (0.12 mmol), and 4-
(chloromercuribenzoic acid) (1 mmol)] to prevent the in vitro
production and degradation of angiotensin peptides. The blood
was centrifuged, and plasma was separated and stored at 220uC.
LV was homogenized in lyses buffer (sodium phosphate 0.1 M,
sucrose 0.34 M, NaCl 0.3 M) containing a mixture of protease
inhibitors and centrifuged at 10 0006g, 4uC, for 10 min., to
determine the measurement of cardiac Ang II. The supernatant
and plasma were collected and passed through phenyl silica
cartridges (Sep-Pak C18 columns, Waters), and the absorbed
angiotensin was eluted with methanol. Eluate was dried in a
vacuum centrifuge and the pellet was re-suspended in EIA buffer,
vortexed and centrifuged at 3000 g for 10 minutes at 4uC. The
results were expressed pg/ml. The tissue protein content was
determined by the Bradford methods [19] by using bovine serum
albumin as the standard (Bio-Rad Protein Assay).
Western blot analysis
The frozen ventricles were thawed and minced into small pieces
and homogenized in cell lysis buffer containing 100 mM Tris,
50 mM NaCl, 10 mM EDTA, 1% TritonX-100 and a mixture of
protease inhibitors. Insoluble heart tissues were removed by
centrifugation at 3,0006g, 4uC, for 10 min. Samples were loaded
and subjected to SDS-PAGE in 10% polyacrylamide gels. After
electrophoresis, proteins were electro-transferred to nitrocellulose
membrane (Amersham Biosciences; Piscataway, NJ). Equal
Table 1. Effects of body composition and aerobic exercise training on BW, HWR, VFP, HR and SBP.
Variables Groups P value
LZR LZR+EXT OZR OZR+EXT BC EXT Interaction
BW before, g 349610.7 342612.3 507617.5**&& 532612.6**&& ,0.0001 NS NS
BW after, g 378613.4 383612.5 600617.1**&& 580618.4**&& ,0.0001 NS NS
Delta BW 4565.7 4064.5 93613 48610## NS NS ,0.01
LVR, g/cm 1.9460.1 1.860.1 2.6560.1*& 2.3160.1*&# ,0.0001 ,0.001 NS
VFP, g 10.7660.97 9.9261.30 85.0066.06**& 68.2562.36**&# ,0.0001 ,0.001 NS
HR, bpm 436615.3 38269.5*# 433621.6 38365.1* NS ,0.01 NS
SBP, mm/Hg 11562 11661.1 12461.7*& 12763.8*& ,0.001 NS NS
LZR. lean Zucker rat; OZR. obese Zucker rat; LZR+EXT. lean Zucker rat plus exercise training; OZR+EXT. obese Zucker rat plus exercise training. (BW) body weight; (LVR)
Left ventricle ratio; (VFP) visceral fat pad; (HR) heart rate; (SBP) systolic blood pressure. Data are reported as means 6 SD of 5 animals in each group.
*p,0.05 versus lean untrained,
**p,0.001 versus lean untrained,
&p,0.05 versus lean trained,
&&p,0.001 versus lean trained,
#p,0.05 versus obese untrained.
doi:10.1371/journal.pone.0046114.t001
Table 2. Effects of body composition and aerobic exercise training on cardiac function.
Variables Groups P value
LZR LZR+EXT OZR OZR+EXT BC EXT Interaction
Systolic function
Ef (%) 0.8360.03 0.7860.08 0.8860.02 0.8460.03 NS NS NS
FS (%) 0.4560.02 0.4260.08 0.5260.03 0.4860.03 NS NS NS
Diastolic function
E/A wave ratio (m/s) 2.0460,11 2.1460.26 1.5460.26 2.2060.62 NS NS NS
IVRT (ms) 22.0062.45 29.4069.13 28.0064.64 29.5063.46 NS NS NS
LVM (g) 0.9860.04 1.1760.03* 1.2460.07* 1.0260.12#& ,0.05 NS ,0.0001
LZR, lean Zucker rat; OZR, obese Zucker rat; LZR+EXT, lean Zucker rat plus exercise training; OZR+EXT, obese Zucker rat plus exercise training. (Ef) Ejection fraction; (FS)
fractional shortening; (IVRT) isovolumetric relaxation time; left (LVM) ventricle mass. Data are reported as means 6 SD of 5 animals in each group.
*p,0.05 versus lean untrained,
&p,0.05 versus lean trained,
#p,0.05 versus obese untrained.
doi:10.1371/journal.pone.0046114.t002
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loading of samples (60 mg) and even transfer efficiency were
monitored with the use of 0.5% Ponceau S staining of the blot
membrane. The blot membrane was then incubated in a blocking
buffer (5% nonfat dry milk, 10 mM Tris-HCl, pH 7.6, 150 mM
NaCl, and 0.1% Tween 20) for 2 h at room temperature and then
probed with a polyclonal antibody directed against AT1 or AT2
(1:1000 or 1:1000, respectively; Santa Cruz Biotechnology Inc.,
Santa Cruz, CA, USA) at room temperature. Primary antibody
binding was detected with the use of peroxidase-conjugated
secondary antibodies, and enhanced chemiluminescence reagents
(Amersham Biosciences; Piscataway, NJ) were used to visualize the
autoradiogram, which was later exposed to photographic film.
The film was developed and the bands were analyzed using Scion
Image software (Scion Corporation based on NIH image).
GAPDH expression levels were used to normalize the results.
Reverse Transcriptase/Real-Time Polymerase Chain
Reaction
The relative gene expression of a myosin heavy chain (aMHC)
and b myosin heavy chain (bMHC) were analyzed by Real-Time
Polymerase Chain Reaction PCR (RT-PCR). Total RNA was
isolated from LV with Trizol reagent (GIBCO Invitrogen). Total
RNA concentration and integrity were assessed and RT-PCR was
performed. RNA samples were quantified by absorbance at
260 nm and 280 nm in order to determine their concentration
and purity levels. Only samples with 260 nm/280 nm index
between 1.8–2.2 were considered. The aMHC and bMHC
mRNA expression were assessed by oligonucleotide primers as
follows: for aMHC, (59-CGA GTC CCA GGT CAA CAA G-39)
and (59-AGG CTC TTT CTG CTG GAC C-39); for bMHC, (59-
CAT CCC CAA TGA GAC GAA G-39), and (59-AGG CTC
TTT CTG CTG GAC A-39) and for ACE (59CAG GAA CGT
GGA ACT TGG A 39) and (59CTT TGA CGC AAG CAT CAC
C 39). The expression of cyclophilin A (59-AAT GCT GGA CCA
AAC ACA AA-39) and (59-CCT TCT TTC ACC TTC CCA AA-
39) was measured as an internal control for sample variation in RT
reaction. Real-Time PCR amplifications were performed with an
ABI Prism 7700 Sequence Detection System (Applied Biosystems), using
SYBR Green PCR Master Mix (Applied Biosystems). All samples were
assayed in triplicate. The results were quantified as Ct values,
where Ct is defined as the threshold cycle of the polymerase chain
reaction at which the amplified product is first detected. Values for
the control gene (cyclophilin) were used to standardize the results
in order to compensate for differences in RNA content among the
samples. The comparative threshold (CT) cycle method was used
for data analyses. CT indicates the fractional cycle number at
which the amount of amplified target reaches a fixed threshold,
and DCT is the difference in threshold cycle for target (aMHC,
bMHC, ACE) and control (cyclophilin). The levels of (aMHC,
bMHC, ACE) gene expression were given by 22DDCT; where
DDCT is the DCT value subtracted from DCT of lean untrained
rats. Finally the 2 fold DDCT was calculated.
Statistical Analysis
All the data were subjected to statistical analyses using the SAS
program. A mixed model was used, with body composition (BC)
(lean and obese) and exercise training (EXT) (untrained and
trained) as fixed factors for all variables, except for body weight,
for which a time factor was included. A Delta (D) Body weight
(Final minus initial protocol body weight) was calculated. When
significance F value was obtained a post-hoc test with Tukey’s
adjustment was performed for multiple comparison purposes.
Results were expressed as means 6 SEMs. Statistical significance
was set at P,0.05.
Table 3. Effects of body composition and aerobic exercise training on metabolic parameters.
Variables Groups P value
LZR LZR+EXT OZR OZR+EXT BC EXT Interaction
Glucose(mg/dl) 12266 12365 13369 14167 NS NS NS
Triglycerides(mg/dl) 3963 3464 23567**&& 135625**&&## ,0.0001 ,0.001 ,0.01
Cholesterol(mg/dl) 6363 6565 12867***&&& 12969***&&& ,0.0001 NS NS
HDL(mg/dl) 4363 4469 2664**&& 3762 ,0.01 NS NS
LDL(mg/dl) 1262 1463 7464***&&& 4567**&&## ,0.0001 ,0.05 ,0.01
LZR, lean Zucker rat; OZR, obese Zucker rat; LZR+EXT, lean Zucker rat plus exercise training; OZR+EXT, obese Zucker rat plus exercise training. (HDL) high density
lipoprotein; (LDL) low density lipoprotein. Data are reported as means 6 SD of 5 animals in each group.
**p,0.001 versus lean untrained,
***p,0.0001 versus lean untrained,
&&p,0.001 versus lean trained,
&&&p,0.0001 versus lean trained
#p,0.05 versus obese untrained,
##p,0.001 versus obese untrained.
doi:10.1371/journal.pone.0046114.t003
Figure 1. Effect of obesity and exercise training on a/b-MHC
(alpha/beta-Myosin Heavy Chain) ratio in rat ventricles. Data are
reported as means 6 SEMs of 5 animals in each group. *p,0.05 versus
lean untrained.
doi:10.1371/journal.pone.0046114.g001
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Results
Body weight, visceral fat pad and left ventricle ratio
Table 1 shows the effects of time, body composition (BC) and
EXT on the Body Weight (BW) and the effects of BC and EXT on
the visceral fat pad (VFP) and left ventricle (LV) ratio. Both obese
groups (OZR, OZR+EXT) showed higher BW before and after
the training protocol when compared with the Lean groups (LZR,
LZR+EXT) (p,0.0001), while no significant EXT effect was
observed. However, when D BW was calculated, a significant
difference was observed (p,0.05) between untrained OZR and the
other groups (LZR, LZR+EXT and OZR+EXT). As regards the
LV ratio, there was a significant BC effect (p,0.0001) and EXT
effect (p,001). Post hoc analyses for individual conditions showed
that untrained OZR had a significant increase (65%) in LV ratio
in comparison with untrained and trained LZR (p,0.001),
however the OZR+EXT showed a significant reduction (15%)
in comparison with untrained OZR (p,0.05). The VFP showed
similar effect results to those of the LV ratio. However, the
differences were bigger (OZR increased 750% in comparison with
LZR) and the exercise training in OZR+EXT decreased (20%)
VFP in comparison with untrained OZR. In addition, these latter
results showed a correlation between the gain in VFP and LV ratio
(r2 = 0.73; p,0.0001).
Hemodynamic parameters
In order to verify the hemodynamic changes and cardiovascular
adaptations in BC and EXT, the HR and SBP were measured at
the end of the training protocol as shown in Table 1. There was a
significant EXT effect (p,0.01) for HR and a significant BC effect
(p,0.001) for SBP. When comparing untrained LZR versus
LZR+EXT, the post hoc analyses showed significant decreased
(12%) in HR (p,0.05), while only a marginal significance was
found for OZR versus OZR+EXT (p= 0.07). The absence of
statistical significance of the HR in the OZR+EXT could be due
to the lower sample size in the study (N= 5) per group.
Cardiac parameters
Table 2 shows the results obtained by echocardiography at the
end of the EXT protocol. The untrained OZR had (26%) LV
mass increase in comparison with both lean groups (LZR and
LZR+EXT) (p,0.05), while the OZR+EXT had (17%) LV mass
decrease in comparison with OZR (p,0.05) as indicated by
individual comparisons in the post hoc test. These results
confirmed our previous data obtained by means of the LV ratio.
Cardiac functions measured by systolic and diastolic parameters
showed no statistical differences, however, although there was no
statistical difference (p = 0.07) a (25%) reduced time E/A wave
ratio was found when OZR was compared with untrained LZR,
Figure 2. Systemic Renin-Angiotensin-System. A) Effect of obesity and exercise training on ACE activity. B) Effect of obesity and exercise
training on Angiotensin II peptide concentration. Data are reported as means 6 SEMs of 5 animals in each group. **p,0.001 versus lean untrained,
&&p,0.001 versus lean trained.
doi:10.1371/journal.pone.0046114.g002
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while OZR+EXT had values close to those of the lean control
group.
Metabolic parameters
To verify whether this obesity model leads to other metabolic
risk factors, and whether the EXT alters these parameters after the
treatment protocol, some plasma components, such as glucose,
total cholesterol, high-density lipoprotein-cholesterol (HDL), low-
density lipoprotein-cholesterol (LDL) and triglycerides were
analyzed. The results are shown in Table 3. In this model,
glucose remained the same in all groups irrespective of BC and
EXT. Triglycerides, total cholesterol and LDL were higher in the
both obese groups (p,0.0001), when compared with both lean
groups. On the other hand only untrained OZR showed decreased
HDL compared to both lean groups. In addition, OZR+EXT
showed lower triglycerides (p,0.001) and LDL cholesterol
(p,0.01) levels in comparison with those of the OZR.
a and b – Myosin Heavy Chain (MHC)
To gain better understanding of whether obese CH is
physiological or pathological, pathological hypertrophy markers,
a and b-MHC were analyzed. There was a significant BC effect on
these cardiac markers (p,0.05), with (65%) decrease in untrained
OZR shown in the post hoc test in comparison with the untrained
LZR. On the other hand, although the a/b-MHC ratio in
OZR+EXT group was not different from OZR, the EXT
prevented the decrease in the a/b-MHC ratio, once the
OZR+EXT were not different from the lean rats (Fig. 1).
Systemic Renin-Angiotensin-System
In order to investigate the role of RAS components in BC and
EXT even further, the systemic RAS and cardiac components
were evaluated. There were no significant effects of BC, EXT and
interaction on serum ACE activity (Fig. 2a). However, as regards
plasma Ang II concentration, untrained OZR showed a decrease
(66%) compared with untrained LZR; and OZR+EXT a decrease
(42%) compared with untrained LZR (Fig. 2b).
Cardiac Renin-Angiotensin-System
LV ACE activity and gene expression, ACE2 activity and
protein expression, Ang II concentration and Ang II receptor
(AT1 and AT2) protein expressions were measured in order to
verify the relationship between cardiac alterations and local RAS
in BC and EXT. Differently from the systemic RAS, there was
significant increase (36% p,0.05; 148% p,0.05) in LV ACE
activity and gene expression in untrained OZR, when compared
with untrained LZR (Figures 3a and 3b). These alterations were
accompanied by high levels of cardiac Ang II (untrained OZR
showed an increase of 90% when compared with untrained LZR;
p,0.001) and AT2 receptor (untrained OZR showed a 50%
increase when compared with untrained LZR; p,0.05), (Figures 4
and 5a, respectively). AT1 protein expressions were the same for
all groups. In the OZR+EXT, swimming training decreased ACE
activity (27% decrease compared with OZR; p,0.05) and
expression (63% decrease compared with OZR; p,0.05), Ang II
concentration (44% decrease compared with OZR; p,0.05) and
AT2 expression (35% decrease compared with OZR; p,0.05),
(Figures 3a, 3b, 3c and 4a, respectively) being comparable with
Figure 3. Cardiac Renin-Angiotensin-System. A) Effect of obesity and exercise training on Cardiac ACE activity. B) Effect of obesity and exercise
training on ACE mRNA expression (Quantification of mRNA ACE was normalized against Cyclophilin mRNA). C) Effect of obesity and exercise training
on concentration of Angiotensin II peptide in rat left ventricle. Data are reported as means 6 SEMs of 5 animals in each group. *p,0.05 versus lean
untrained, **p,0.001, &p,0.001 versus lean trained, #p,0.05 versus obese untrained.
doi:10.1371/journal.pone.0046114.g003
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values shown for LZR. Moreover, EXT increased ACE2 activity
(LZR+EXT showed a 24% increase compared with LZR; p,0.05
and OZR+EXT showed a 30% increase compared with OZR;
p,0.05), and protein expression (LZR+EXT showed a 74%
increase compared with OZR; p,0.05 and OZR+EXT showed a
81% increase compared with OZR; p,0.05) in both trained
groups irrespective of BC, demonstrating the beneficial effect of
exercise per se on ACE2, (Figures 5a and 5b).
Discussion
Obesity is a chronic disease and can lead to several other
pathologies, involving diabetes mellitus type 2, hypertension, some
lipid disorders and other cardiac disorders [4,20–21]. Indeed,
obesity is an independent factor for the development of cardiac
disorders, and this association is one of the most common causes of
death [22]. Therefore, it is important to understand the
mechanisms responsible for this pathological condition and create
therapeutic strategies, such as the use of drugs or exercises that
modulate obesity-related cardiac disease.
As shown in the literature, the genetically obese Zucker rat, a
widely used model, has a large amount of adipose tissue and
abnormally large numbers of large fat cells, which synthesize fatty
acids and triglycerides at increased rates, which in turn, lead to
some metabolic disorders involving triglyceride and cholesterol
metabolism [23–25]. The obese group in the present study had
elevated triglycerides, total cholesterol and LDL, and decreased
HDL. On the other hand, swimming training in obese rats
improved this condition by lowering triglycerides and LDL
cholesterol and augmenting HDL cholesterol. These changes are
important, because these metabolic alterations can contribute to
cardiac modifications [26], such as cardiac metabolic disorders
and increased cardiac mass [27], as seen in the Zucker model
[8,10]. Likewise, in the untrained obese Zucker rats in this study,
increased cardiac mass, measured by cardiac weight and
echocardiography were found. However, swimming training in
the obese group decreased cardiac mass, which together with the
metabolic parameters are important to improve cardiac condi-
tioning in obesity. The higher cardiac mass in the untrained obese
rats was accompanied by lower levels of molecular a/b MHC
ratio. This modification suggests a cardiac pathological condition
Figure 4. Cardiac Angiotensin II receptors. A) Effect of obesity and exercise training on AT1 protein expression analyzed by Western blot. B)
Effect of obesity and exercise training on AT2 protein expression analyzed by western blot. Data are reported as means 6 SEMs of 5 animals in each
group. *p,0.05 versus lean untrained. #p,0.05 versus obese untrained.
doi:10.1371/journal.pone.0046114.g004
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resembling fetal gene reprogram [28]. The molecular mechanisms
involved in cardiac modifications in obesity and exercise training
are not fully understood.
Studies that used ACE inhibitors have suggested that the RAS
seems to play a critical role in cardiac modifications [7,27].
However, although some studies have shown that the RAS can
participate in cardiac diseases related to obesity, they did not
measure the cardiac RAS components [8,27]. For the first time, in
the present study, the local cardiac RAS components were
measured in obese rats, and here they provide direct evidence of
involvement of the local cardiac RAS components in obese rats;
and that local cardiac RAS involvement is independent of the
systemic RAS in this obese model and that EXT can indepen-
dently modulate local and systemic RAS. Furthermore, some
authors have demonstrated that EXT can be an interesting tool for
non-pharmacological treatment of some cardiovascular diseases
[12–14,29]. In this study it was demonstrated that EXT is an
important therapeutic strategy to combat obesity by reducing
weight gain, improving the metabolic parameters, and most
importantly, down-regulating the pathological cardiac RAS
components and bringing them to levels similar to those observed
in LZR.
The local cardiac RAS changes were independent of circulating
RAS, as lower levels of systemic Ang II were found for both obese
groups with no change in serum ACE activity, it is not known by
which means the systemic Ang II concentration is decreased
despite normal ACE activity. Studies with focus on circulating
RAS are controversial. Differences in obesity models seem to play
a critical role in systemic RAS. Some studies with diet-induced
obesity in Wistar and Sprague-Dawley rats showed increase
circulating levels of Ang II [11,30]. The systemic ACE was not
measured in these studies. On the other hand, Engeli et al [31].
did not find any difference in the systemic Ang II levels in obese
humans, while the renin, ACE and angiotensinogen levels were
elevated. Up to now, there are no studies that measure plasma Ang
II concentration in Zucker rats. Nevertheless, differently from
other obesity models, the obese Zucker rats have low plasma levels
of renin [32–34]. The lower renin levels could be the possible
mechanism by which the Ang II was lower in our obese Zucker
rats because, under most physiological conditions, the rate-limiting
step for ANG II generation is the cleavage of Ang I from
Figure 5. Cardiac Angiotensin Converting Enzyme 2 (ACE2). A) Effect of obesity and exercise training on Cardiac ACE 2. B) Effect of obesity
and exercise training on ACE2 protein expression analyzed by western blot. Data are reported as means 6 SEMs of 5 animals in each group. *p,0.05
versus lean untrained, #p,0,05 versus obese untrained.
doi:10.1371/journal.pone.0046114.g005
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angiotensinogen by aspartyl protease renin. Furthermore, studies
that found an increase in vascular Ang II sensitivity in obese
Zucker rats [34–35], support our findings, since the lower
circulating Ang II levels are probably responsible for this alteration
in vascular sensitivity.
Differently from the systemic condition, in this obesity model an
increase in cardiac ACE activity and gene expression was found,
followed by higher levels of Ang II and AT2 receptor. On the
other hand, reduced cardiac ACE, Ang II and AT2 receptor were
observed in OZR+EXT, and these modifications were accompa-
nied by a reduction in cardiac mass. Clinical and genetic studies
have demonstrated an influence of RAS on CH [36–37]. Huang et
al. [10] observed an increase in cardiac AT1 expression in Zucker
rats and demonstrated that a decrease in cardiac mass is at least in
part, associated with modulation of cardiac AT1 expression.
However, in this study the Zucker rats were diabetics, which differs
from our Zucker model. In the present study, it was not possible
find an alteration in AT1 receptor protein expression, however,
higher levels of AT2 receptor protein expression were observed in
untrained obese rats. Unfortunately, there are no studies that have
measured cardiac AT2 in obese rats. However, D’Amore et al.
showed that in cardiomyocytes, the AT2 receptor causes
constitutive growth and does not oppose the actions of the AT1
receptor. Another possible mechanism by which the AT2
expression is up-regulated, is to oppose some deleterious effects
[38–39]. It is well established that the obese Zucker rat has cardiac
metabolic disorders, which in turn lead to an increase in the
apoptotic pathway [40]. Furthermore, as shown by Goldenberg et
al, the increase in the AT2 leads to an increase in the apoptotic
pathway [41]. Therefore, the increase in cardiac AT2 receptor
protein levels could probably counteract the deleterious effect in
this model, since exercise training in OZR+EXT decreased AT2
to normal levels when compared with their untrained littermates.
Taken together, these results suggest that the increase in AT2
protein levels in the present study could have been produced by
three main mechanisms: counteracting the deleterious effects of
obesity, promoting cardiac hypertrophy and increasing apoptotic
signaling.
The results of the present study also demonstrated that EXT
down-regulated ACE, Ang II and AT2 in the obese group. These
latter results are in agreement with previous results observed in the
authors’ laboratory, in which it was observed that aerobic exercise
training in healthy Wistar rats had some effects on the RAS, such
as decreased cardiac ACE and Ang II and increased cardiac
ACE2 and Ang 1–7 [15]. Moreover, Pereira et al [12] in a genetic
mouse model also showed a beneficial effect of aerobic exercise on
the cardiac RAS components. Filho et al [29] showed that aerobic
training increased LV Ang 1–7 levels in swimming-trained a
model of spontaneously hypertensive rats. In parallel, it was
observed that exercise increased both receptor Mass mRNA and
protein levels in the heart, suggesting that an overall activation of
the Ang 1–7 – Mass axis may be involved in the beneficial effects
of physical training in hypertensive disease. Thus, it seems that
exercise training alters the cardiac RAS components, and these
modifications are beneficial to the heart in some cases of cardiac
pathology.
Finally, irrespective of whether the animals were obese or not,
exercise increased cardiac ACE2 in both trained groups, as shown
in Figure 5. It is known that ACE2 can cleave Ang II into
Angiotensin 1–7 (Ang 1–7) [42]. Ang 1–7 has a vasodilator effect
and inhibits pathological cardiac growth [43]. Therefore, elevating
ACE2 levels could be beneficial in obesity.
In summary, the results of the present study showed that cardiac
mass, cardiac ACE activity and gene expression, as well as Ang II
concentration were increased, although systemic Ang II was
decreased in a Zucker genetic model of obesity. Exercise training
increases cardiac ACE2 activity and protein expression and
prevents the increase in cardiac mass, cardiac ACE, Ang II, AT2
caused by obesity. Therefore, the above results demonstrated that
in a genetic model of obesity, pathological cardiac hypertrophy
markers are increased together with increased cardiac RAS
activity and expression; however, aerobic exercise training
prevents cardiac hypertrophy in this model and decreases cardiac
RAS activity and expression, suggesting that aerobic exercise
training modulates cardiac RAS in the context of obesity.
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